References

Samuel VT, Petersen KF, Shulman GI. Lipid-induced insulin resistance: unravelling the mechanism. Lancet. 2010;375:2267-77. Pubmed

Serra Majem L, Ribas Barba L, Aranceta Bartrina J, Pérez Rodrigo C, Saavedra-Santana P, Peña Quintana L. [Childhood and adolescent obesity in Spain.Results of the enKid study (1998-2000)]. Med Clin (Barc).2003;121:725-32. Spanish. Pubmed

Gómez-Ambrosi J, Azcona C, Patiño-García A, Frühbeck G. Serum Amyloid A concentration is increased in obese children and adolescents. J Pediatr. 2008 Jul;153(1):71-5.Pubmed

Fitó M, Guxens M, Corella D, Sáez G, Estruch R, de la Torre R, Francés F, Cabezas C, López-Sabater Mdel C, Marrugat J, García-Arellano A, Arós F, Ruiz-Gutierrez V, Ros E, Salas-Salvadó J, Fiol M, Solá R, Covas MI; for the PREDIMED Study Investigators. Effect of a traditional Mediterranean diet on lipoprotein oxidation: a randomized controlled trial. Arch Intern Med.
2007;167(11):1195-203.Pubmed

Tomkin GH. Atherosclerosis, diabetes and lipoproteins. Expert Rev Cardiovasc Ther. 2010;8:1015-29. Review. Pubmed

Hassanali Z, Ametaj BN, Field CJ, Proctor SD, Vine DF. Dietary supplementation of n-3 PUFA reduces weight gain and improves postprandial lipaemia and the associated inflammatory response in the obese JCR:LA-cp rat. Diabetes Obes Metab. 2010;12:139-47. Pubmed

Kypreos KE, Karagiannides I, Fotiadou EH, Karavia EA, Brinkmeier MS, Giakoumi SM, Tsompanidi EM. Mechanisms of obesity and related pathologies: role of apolipoprotein E in the development of obesity. FEBS J. 2009;276:5720-8. Review. Pubmed

Niu YG, Evans RD. Myocardial metabolism of triacylglycerol-rich lipoproteins in type 2 diabetes. J Physiol. 2009;587:3301-15. Pubmed

Wang H, Eckel RH. Lipoprotein lipase: from gene to obesity. Am J Physiol
Endocrinol Metab. 2009;297:E271-88. Pubmed

Eleftheriadou I, Grigoropoulou P, Katsilambros N, Tentolouris N. The effects of medications used for the management of diabetes and obesity on postprandial lipid metabolism. Curr Diabetes Rev. 2008;4:340-56. Pubmed